In-patient COVID-19 Study of Intranasal Foralumab

NCT04983446 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Withdrawn due to business reasons

Conditions

Covid19
COVID-19 Lower Respiratory Infection
COVID-19 Respiratory Infection

Interventions

DRUG: Foralumab
OTHER: Placebo

Sponsor

Tiziana Life Sciences LTD